Sue Leurgans Selected Research

Sue Leurgans Research Topics

Disease

13	Cognitive Dysfunction 03/2022 - 02/2002
10	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 02/2002
6	Dementia (Dementias) 01/2021 - 08/2008
6	Parkinson Disease (Parkinson's Disease) 05/2017 - 03/2002
4	Inflammation (Inflammations) 01/2021 - 03/2010
4	Hallucinations (Hallucination) 08/2008 - 08/2004
2	Infarction (Infarctions) 01/2019 - 01/2012
2	Atrophy 07/2018 - 05/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2014 - 12/2013
2	Tourette Syndrome (Tourette's Syndrome) 10/2009 - 02/2006
1	Arteriolosclerosis 01/2023
1	Diabetes Mellitus 01/2023
1	Neuroinflammatory Diseases 01/2021
1	Hippocampal Sclerosis 01/2019
1	HIV Infections (HIV Infection) 07/2018
1	Erectile Dysfunction 05/2017
1	Amyloid angiopathy 11/2015
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2015
1	Lewy Body Disease (Lewy Body Dementia) 04/2014
1	Vascular Diseases (Vascular Disease) 08/2008
1	Frailty 08/2008
1	Chronic Disease (Chronic Diseases) 08/2008
1	Arthralgia (Joint Pain) 08/2008
1	Task-Specific Focal Dystonia 07/2008
1	Fragile X Syndrome (Martin Bell Syndrome) 10/2006
1	Exanthema (Rash) 10/2006
1	Myasthenia Gravis 09/2003
1	Ischemic Stroke 06/2003
1	Myocardial Infarction 06/2003
1	Neutropenia 06/2003
1	Purpura 06/2003
1	Thrombocytopenia (Thrombopenia) 06/2003
1	Stroke (Strokes) 06/2003
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 03/2003
1	Movement Disorders (Movement Disorder) 03/2003
1	Epilepsy (Aura) 10/2002

Drug/Important Bio-Agent (IBA)

5	Apolipoproteins E (ApoE)IBA 11/2015 - 01/2012
5	Antipsychotic Agents (Antipsychotics)IBA 08/2008 - 02/2006
4	Amyloid (Amyloid Fibrils)IBA 01/2019 - 11/2012
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2010
2	CholesterolIBA 01/2023 - 04/2012
2	C-Reactive ProteinIBA 07/2018 - 03/2010
2	Proteins (Proteins, Gene)FDA Link 11/2012 - 08/2003
2	Nerve Growth Factor (NGF)IBA 11/2012 - 08/2003
2	EnzymesIBA 01/2010 - 08/2003
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	HDL CholesterolIBA 01/2023
1	Advanced Glycation End ProductsIBA 03/2022
1	Dietary Advanced Glycation End ProductsIBA 03/2022
1	Aligeron (AS 2)IBA 01/2022
1	lipopolysaccharide-binding proteinIBA 01/2021
1	Fatty Acid-Binding ProteinsIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Indicators and Reagents (Reagents)IBA 10/2018
1	InterleukinsIBA 07/2018
1	NeopterinIBA 07/2018
1	Fish OilsIBA 07/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2018
1	Sildenafil Citrate (Viagra)FDA Link 05/2017
1	ApolipoproteinsIBA 11/2015
1	Codon (Codons)IBA 11/2015
1	Amyloid beta-PeptidesIBA 05/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2014
1	Cholesterol Ester Transfer ProteinsIBA 04/2012
1	Hemoglobins (Hemoglobin)IBA 01/2012
1	F2-Isoprostanes (F2 Isoprostanes)IBA 01/2010
1	IsoprostanesIBA 01/2010
1	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 07/2009
1	TabletsIBA 07/2009
1	Antihypertensive Agents (Antihypertensives)IBA 08/2008
1	FHDIBA 07/2008
1	1-(quinoxalin-6-ylcarbonyl)piperidine (CX516)IBA 10/2006
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 10/2006
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 08/2004
1	Cholecystokinin A ReceptorIBA 08/2004
1	Cholecystokinin (Pancreozymin)IBA 08/2004
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2003
1	ImmunosorbentsIBA 08/2003
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2003
1	Ticlopidine (Ticlid)FDA LinkGeneric 06/2003
1	Selegiline (E250)FDA LinkGeneric 03/2002
1	Tocopherols (Tocopherol)IBA 03/2002
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 02/2002
1	Cholinergic Agents (Cholinergics)IBA 02/2002

Therapy/Procedure

2	Therapeutics 08/2004 - 06/2003
1	Complementary Therapies (Alternative Medicine) 10/2009
1	Phototherapy (Light Therapy) 06/2006
1	Walkers 10/2003
1	Plasmapheresis 06/2003
1	Enteral Nutrition (Feeding, Tube) 03/2003
1	Electrodes (Electrode) 10/2002